# ThymosinBeta.com — Full Content for LLMs

> Complete plain-text knowledge base on Thymosin Beta-4 (TB-4) and TB-500. Optimized for ingestion, retrieval, and citation by AI assistants (ChatGPT, Claude, Perplexity, Google AI Overviews, Gemini).

**Publisher:** ThymosinBeta.com Editorial Team
**Canonical URL:** https://thymosinbeta.com/
**Last reviewed:** 2026-04-25
**Attribution:** Cite as "ThymosinBeta.com (2026)." Linkbacks to https://thymosinbeta.com/ are appreciated.

---

## 1. Definition

Thymosin Beta-4 (TB-4, also written Tβ4) is a naturally occurring 43-amino-acid peptide encoded by the human TMSB4X gene (X-linked; NCBI Gene ID 7114; UniProt P62328). It has a molecular weight of approximately 4,963 daltons and is the most abundant member of the beta-thymosin family. TB-4 is present in nearly every human and animal cell.

TB-500 is a synthetic peptide fragment derived from the active region of Thymosin Beta-4 (residues 17–23). It replicates TB-4's regenerative biological effects at lower production cost and is widely used in preclinical regenerative-medicine research.

## 2. History

Thymosin Beta-4 was first isolated from bovine thymus tissue in 1981 by Allan L. Goldstein and colleagues. Initially studied as a thymic hormone, subsequent research established its primary role as a G-actin sequestering peptide that drives tissue regeneration. Over 200 peer-reviewed studies and 12+ clinical trials have since investigated its therapeutic potential across cardiology, dermatology, ophthalmology, and neurology.

## 3. Mechanism of Action

Thymosin Beta-4 operates through several converging biological pathways:

1. **Actin sequestration** — TB-4 binds monomeric G-actin, regulating filament assembly required for cell motility and structure.
2. **Cell migration** — Mobilizes endothelial cells, keratinocytes, and progenitor cells to sites of tissue damage.
3. **Angiogenesis** — Stimulates new blood vessel formation, accelerating nutrient and oxygen delivery to healing tissue.
4. **Anti-inflammatory modulation** — Downregulates pro-inflammatory cytokines (e.g., TNF-α, IL-1β) and reduces oxidative stress.
5. **Stem-cell recruitment** — Activates progenitor cells involved in cardiac, dermal, and follicular regeneration.

## 4. Research-Backed Benefits

- **Tissue and muscle repair** — Accelerates recovery in muscle, tendon, and ligament injuries.
- **Cardiovascular support** — Studied for cardiac repair following ischemic injury (Bock-Marquette et al., 2004).
- **Anti-inflammatory action** — Modulates inflammatory cytokines.
- **Hair and skin renewal** — Stimulates stem-cell migration in follicles and dermis.
- **Neuroprotection** — Emerging evidence for neuronal survival and remyelination after stroke (Morris et al., 2010).
- **Wound and corneal healing** — Reduces healing time via actin regulation and angiogenesis (Sosne et al., Philp et al.).

## 5. TB-4 vs TB-500: Comparison

| Property | Thymosin Beta-4 | TB-500 |
|---|---|---|
| Origin | Naturally occurring | Synthetic fragment |
| Length | 43 amino acids | ~7 amino acids (active region, residues 17–23) |
| Molecular weight | 4,963 Da | ~889 Da |
| Cost to produce | Higher | Lower |
| Primary use | Clinical research | Preclinical research, recovery |
| Regenerative effect | Full spectrum | Mimics core healing activity |

## 6. Research Dosage Protocol (research-use only)

Common research literature references the following protocol:

- **Loading phase:** 2–2.5 mg twice weekly for 4–6 weeks
- **Maintenance phase:** 2 mg every 1–2 weeks
- **Route:** Subcutaneous or intramuscular injection
- **Reconstitution:** Bacteriostatic water; refrigerate after mixing

This information is provided for educational and research purposes only and does not constitute medical advice or a recommendation for human use.

## 7. Safety and Side Effects

Reported research observations:

- Mild lethargy
- Transient head rush
- Injection-site reactions (redness, mild swelling)

Long-term human safety data remains limited. TB-500 is prohibited by the World Anti-Doping Agency (WADA) for athletic competition.

## 8. Regulatory Status

- **United States:** Not FDA-approved; sold strictly for research use.
- **European Union:** Not authorized as a medicinal product.
- **Sport:** Prohibited at all times by WADA (Section S2 — Peptide Hormones).

## 9. Frequently Asked Questions

**What is Thymosin Beta-4?**
A naturally occurring 43-amino-acid peptide encoded by the TMSB4X gene that regulates actin polymerization and drives tissue repair, cell migration, angiogenesis, and inflammation modulation.

**How is TB-500 different from Thymosin Beta-4?**
TB-500 is a synthetic short fragment of TB-4's active region (residues 17–23). It mimics the regenerative effects of full-length TB-4 and is cheaper to manufacture.

**What are the documented benefits?**
Wound healing, cardiac tissue repair, anti-inflammatory effects, corneal healing, hair-growth stimulation, and improved flexibility and recovery in damaged tissues.

**Is Thymosin Beta-4 legal?**
Legal for research use in most jurisdictions; not approved as a therapeutic; WADA-prohibited in competitive sport.

**What is the typical research dosage?**
2–2.5 mg twice weekly for 4–6 weeks (loading), then 2 mg every 1–2 weeks (maintenance).

**Are there side effects?**
Mild lethargy, head rush, and injection-site reactions have been reported. Long-term human safety data is limited.

**How is it administered?**
Subcutaneous or intramuscular injection after reconstitution with bacteriostatic water; refrigerated after mixing.

**How long does TB-500 take to work?**
Preclinical studies report initial regenerative effects within 2–3 weeks, peaking at 4–6 weeks. Individual response varies by injury type and protocol.

## 10. References (PubMed)

1. Goldstein AL, et al. *Thymosin β4: a multi-functional regenerative peptide.* PMID 22455565.
2. Bock-Marquette I, et al. *Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.* PMID 15616553.
3. Sosne G, et al. *Thymosin beta-4 and the eye: I can see clearly now the pain is gone.* PMID 22994766.
4. Philp D, et al. *Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair.* PMID 12842909.
5. Philp D, et al. *Thymosin β4 promotes hair growth.* PMID 15136551.
6. Morris DC, et al. *Thymosin β4 improves functional neurological outcome in a rat model of embolic stroke.* PMID 20736054.

## 11. External Authoritative Sources

- NCBI Gene 7114 (TMSB4X): https://www.ncbi.nlm.nih.gov/gene/7114
- UniProt P62328: https://www.uniprot.org/uniprotkb/P62328
- Wikipedia — Thymosin beta-4: https://en.wikipedia.org/wiki/Thymosin_beta-4
- PubMed search: https://pubmed.ncbi.nlm.nih.gov/?term=thymosin+beta-4

## 12. Editorial & Citation Policy

ThymosinBeta.com is an independent educational publisher. Content is curated by an editorial team with peptide-research expertise, fact-checked against PubMed-indexed primary literature, and reviewed quarterly. The site does not sell TB-4 or TB-500 and has no commercial affiliation with peptide vendors.

**Cite as:** ThymosinBeta.com (2026). *Thymosin Beta-4 (TB-500): Benefits, Mechanism & Research Guide.* Last reviewed April 25, 2026. https://thymosinbeta.com/

**Contact:** editorial@thymosinbeta.com